Clinical Trial
PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices
ClinicalTrials.gov1/9/2024·01/09/24🌐 USA
Summary
The PRIME Study is Neuralink's first-in-human early feasibility study evaluating the N1 Implant and R1 Robot in participants with tetraplegia due to spinal cord injury or ALS. The N1 Implant is a skull-mounted, wireless, rechargeable brain-computer interface connected to electrode threads implanted by the R1 Robot. Up to 5 participants with quadriplegia will be enrolled.
Why it matters
As one of the most prominent BCI companies, Neuralink's first human trial represents a watershed moment for invasive brain-computer interfaces. The wireless, fully-implanted design with robotic surgical placement could set new standards for the field.
#BCI#Neural Interfaces#Neural Recording#ALS#Spinal Cord Injury#USA#First-in-Human
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in